ONC Q2 2022 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q2 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$342M+127.7% YoY

Gross Profit

$270M79.2% margin

Operating Income

-$439M-128.6% margin

Net Income

-$566M-165.6% margin

EPS (Diluted)

$-5.59

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

-$380M

Free Cash Flow

-$430M

Stock-Based Comp.

$81M

Balance Sheet

Total Assets

$7.4B

Total Liabilities

$2.1B

Stockholders' Equity

$5.3B

Cash & Equivalents

$4.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$342M	$150M	+127.7%
Gross Profit	$270M	$114M	+137.8%
Operating Income	-$439M	-$475M	+7.5%
Net Income	-$566M	-$480M	-17.8%